The global homatropine methylbromide market is expected to grow at a significant CAGR during the forecast period (2021-2027). The drug homatropine methylbromide belongs to a class of drugs known as anti-muscarinic. Homatropine is used to treat ulcers in the duodenum and stomach, as well as intestinal issues. In the treatment of peptic ulcers, it can be used with antacids or other medications. It can also be used to prevent motion sickness, nausea, and vomiting.

Homatropine is a muscarinic acetylcholine receptor antagonist with a quaternary ammonium structure. Through the action of G proteins, the muscarinic acetylcholine receptor mediates a variety of physiological responses, including inhibition of adenylate cyclase, phosphoinositide breakdown, and potassium channel regulation. Homatropine methylbromide inhibits acetylcholine's muscarinic effects on tissues innervated by postganglionic cholinergic neurons as well as smooth muscles that react to acetylcholine however are not innervated by cholinergic nerves. Smooth muscle autonomic effector cells, cardiac muscle, sinoatrial and atrioventricular nodes, and exocrine glands all have postganglionic receptor sites. Anticholinergics may lower gastrointestinal motility and secretory activity, as well as the tone of the ureter and urine bladder, and may have a mild relaxing effect on the bile ducts and gallbladder.

According to the NCBI, with age, the prevalence of gastric and duodenal ulcers rose. Females have a significantly lower incidence of duodenal and stomach ulcers than men in patients under 60 years old. In H. pylori-infected individuals, the prevalence of duodenal and stomach ulcers was significantly greater than in those who did not have H. pylori infection. Thus, the rising incidences of peptic ulcers in the geriatric population are expected to drive the market growth for the global homatropine methylbromide market during the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Type – Injectable, Tablets

• Competitive Landscape: Centroflora, Hubei Biocause Pharmaceutical, Pioneer Agro Industries, Resonance Laboratories, Saurav Chemicals, Vital Laboratories. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Homatropine Methylbromide Market by Segments

By Type

• Injectable
• Tablets

Global Homatropine Methylbromide Market by Region